当前位置: 首页 > 期刊 > 《中国健康月刊·A版》 > 2010年第6期
编号:12029879
神经氨基酸类递质与麻醉药的相互影响(3)
http://www.100md.com 2010年6月1日 《中国健康月刊·A版》 2010年第6期
     [17] Sharma PT, Sieber FE, Zakriya KJ, et al. Recovery room delirium predicts postoperative delirium after hip-fracture repair[J]. Anesth Analg, 2005 Oct,101(4):1215-20.

    [18] Renner UD, Oertel R, Kirch W. Pharmacokinetics and pharmacodynamics in clinical use of scopolamine [J]. Ther Drug Monit. 2005 Oct;27(5):655-65.

    [19] Minami M, Nakagawa T,Seki T, et al. A single residue, Lys1O8, of the △ -opioid receptor prevents the μ-opioid-selective ligand [D-Ala(2), N-MePhe(4), Gly-ol(5)]enkephalin from binding to the △-opioid receptor[J]. Mol Pharmacol, 2006, 50:1413-22.

    [20] Claude PA, Wotta DR, Zhang XH. et al. Mutation of as conserved serine in TM4 of opioid receptors confers full agonist properties to classical antagonists[J]. Proc Natl Acad Sci USA 2005,93:5715-9.

    [21] Crain SM, Shen K-F. Opioids can evoke direct receptor-mediated excitatory effects on sensory neurons[J]. Trends Pharmacol Sci, 2006,11:77-81.

    [22] Crain SM, Shen K-F. Antagonists of excitatory opioid receptor functions enhance morphine's analgesic potency and attenuate opioid tolerance / dependence liability[J]. Pain 2002, 84:121-31., http://www.100md.com
上一页1 2 3